Rapid Diagnostic Centres (RDCs) and the roll out of personalised care are cornerstones of the implementation plans for Cancer Alliances...

The annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical...

The All Members meeting was a very informative and enjoyable session, which featured a mix of great speakers. Jennifer Mitchell and Laura...

On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn...

Cancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less...